1. All of the plaintiffs' claims are dismissed.

2. The costs of lawsuit are assessed against the plaintiffs.

1. Basic facts

A. On March 2010, the deceased A (hereinafter “the deceased”) (hereinafter “the deceased”) discovered approximately 10.7 cm around the left-hand extension at the time it was transferred to the Defendant Gyeongbuk University Hospital (hereinafter “Defendant Hospital”).

By the medical personnel of the defendant hospital, an diversative and dypical dypical dypical dypological dypological dypological dypological dypological dypological dypological d

B. The deceased was classified as a high-risk group patient with a death rate of 40 to 60% within 5 years, and the death rate of 30 to 40% within 5 years, and the medical professionals at the Defendant hospital need to enforce the auxiliary cancer.

C. On June 24, 2010, the Deceased was hospitalized in the Defendant Hospital for the treatment of assistive Port Cancer Act.

Before using cell toxicity cancer, the medical team at Defendant Hospital performed the physical examination, blood test, past history, etc. of the deceased, and as a result, there was no problems such as white blood cells, blood plate, hyeogle, climatic dyeology, etc., and there was no abnormal gyeological or dyeological dyeology, etc.

Accordingly, the medical personnel of the defendant hospital from June 28, 2010 to the same year.

7. 1. By the end of January, 1, 200, Libera 20 g/m20 m2/m2 per day, Amera 1, Amera 20 m2/m2 per day, and 5 m2/m2 per day, Amera, as Libera, was administered to Amera, on Amera.

The total amount of contribution to the deceased of Abspathad was 15g/m2 (=5g/m2 x 3 days).

E. After the Deceased’s discharge was conducted through an anti-chemical therapy as seen above, the Deceased did not appeal symptoms, such as reduction of urine, urology, urology, and baturology at the time of discharge.

On July 5, 2010, the Deceased promised to provide outpatient treatment to the Defendant Hospital.

F. The Deceased was transferred to the Defendant Hospital on July 5, 2010.